Influenza Hemagglutinin (HA) Peptide: High-Fidelity Epitope Tag for Molecular Biology

Executive Summary: The Influenza Hemagglutinin (HA) Peptide is a synthetic nine-amino acid epitope tag (sequence: YPYDVPDYA) derived from the human influenza virus hemagglutinin protein. It enables highly specific detection and purification of HA-tagged proteins through competitive binding to anti-HA antibodies (APExBIO). The peptide exhibits high solubility in DMSO (≥55.1 mg/mL), ethanol (≥100.4 mg/mL), and water (≥46.2 mg/mL), supporting diverse experimental workflows. Purity is confirmed at >98% by HPLC and mass spectrometry, ensuring reproducibility in immunoprecipitation and protein-protein interaction studies. Storage at -20°C (desiccated) preserves biological activity and stability (see product datasheet). The HA tag is a gold standard for molecular biology research requiring robust epitope tagging (see review).

Biological Rationale

The HA tag peptide is derived from the influenza virus hemagglutinin protein, specifically the YPYDVPDYA sequence. This sequence is recognized by monoclonal anti-HA antibodies, enabling its use as a universal epitope tag (Nature Chemical Biology). Epitope tagging with short, highly immunogenic peptides like HA allows for the detection, localization, and purification of target proteins in heterologous expression systems. The utility of the HA tag arises from its minimal interference with protein folding and function, as well as its compatibility with established immunoassays and affinity purification techniques.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide functions as a competitive ligand for anti-HA antibodies. When introduced into immunoprecipitation (IP) or affinity purification workflows, the free HA peptide competes with HA-tagged proteins for binding sites on anti-HA antibodies (see comparative study). This competitive binding enables the specific elution of HA-tagged fusion proteins from antibody-conjugated matrices. The underlying mechanism exploits the high affinity and selectivity of the anti-HA antibody-epitope interaction, allowing for rapid, gentle recovery of protein complexes under non-denaturing conditions. The peptide's high solubility in aqueous and organic solvents ensures efficient delivery during the elution step.

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) enables specific detection of HA-tagged proteins in immunoassays with minimal background (Nature Chemical Biology).
• Competitive elution using the Influenza Hemagglutinin (HA) Peptide yields >95% recovery of HA-tagged proteins from anti-HA beads under physiological pH (7.4) at 4°C (APExBIO).
• Purity >98% by HPLC and mass spectrometry is validated for SKU A6004, supporting reproducibility in protein-protein interaction studies (Angiotensin-1-2-1-9.com).
• Solubility is confirmed at ≥46.2 mg/mL in water, ≥100.4 mg/mL in ethanol, and ≥55.1 mg/mL in DMSO, facilitating flexible protocol design (APExBIO).
• Storage at -20°C (desiccated) preserves peptide stability for >12 months; solutions are not recommended for long-term storage due to hydrolysis risk (LabPE.com).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is widely used in:

• Protein tagging for recombinant expression and detection in eukaryotic and prokaryotic systems.
• Immunoprecipitation and competitive elution of HA-tagged fusion proteins in cell lysates (see ESCRT-independent pathway review).
• Protein-protein interaction studies to dissect complex formation and dissociation.
• Epitope tagging for localization and quantitation in imaging and immunoblotting assays.

However, limitations must be considered:

• HA peptide cannot displace proteins bound via non-epitope mediated interactions.
• Overuse of peptide may saturate antibody binding sites, reducing specificity.
• Tag placement (N- or C-terminal) and linker selection can influence protein folding and function.

Common Pitfalls or Misconceptions

• Misconception: The HA Peptide can elute non-HA-tagged proteins.
  Fact: Only HA-tagged proteins are eluted via competitive binding; non-tagged proteins remain bound or are not captured.
• Pitfall: Extended storage of peptide solutions leads to degradation.
  Recommendation: Prepare fresh aliquots and store lyophilized peptide desiccated at -20°C.
• Misconception: The HA tag is always inert to protein structure.
  Fact: In rare cases, tag placement may affect protein folding; empirical validation is advised.
• Pitfall: Excess peptide in elution can inhibit downstream antibody-based detection.
  Recommendation: Thoroughly remove eluted peptide prior to further immunoassays.

Workflow Integration & Parameters

The Influenza Hemagglutinin (HA) Peptide (SKU A6004) is compatible with standard immunoprecipitation workflows. For elution, a 1 mg/mL solution in PBS (pH 7.4) is commonly used, with incubation at 4°C for 15–30 minutes. Solubility parameters: water (≥46.2 mg/mL), ethanol (≥100.4 mg/mL), DMSO (≥55.1 mg/mL). Lyophilized peptide should be stored desiccated at -20°C; avoid repeated freeze-thaw cycles. APExBIO recommends using the peptide with Anti-HA Magnetic Beads or conventional anti-HA antibodies for optimal performance (product page). This article extends previous scenario-driven guidance (LabPE.com) by providing updated solubility and storage benchmarks for SKU A6004.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains the gold standard for protein epitope tagging, offering high specificity, solubility, and reproducibility. Advances in peptide synthesis and antibody engineering continue to refine its performance in multiplexed detection and purification workflows. For further mechanistic insight and advanced strategies, see the updated analysis (GTP-binding protein review) that expands on competitive binding and high-purity elution. APExBIO’s HA Peptide (SKU A6004) exemplifies the high-purity, validated standards required for precision molecular biology research.